Kancera AB logo

Kancera AB

Kancera carries out pharmaceutical development, starting with new treatment concepts and ending with the sale of a drug candidate to international pharmaceutical companies.

[stock_market_widget type=”leaderboard” symbol=”3EE.F” template=”background” color=”yellow”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://kancera.com
Founded
Disease Focus
Development Stage
STOCK CODE FRA: 3EE
Address
Karolinska Institutet Science Park, Banvaktsvägen 22, SE-171 48
Solna
Sweden
Email
Contact Number
+46 (0)850 12 60 80

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/kancera-ab” connections=”true” suffix=””]